Organisation paid for research Program year 2025 Source: CMS Open Payments

Georgetown University Medical Ctr

Neither a doctor nor a teaching hospital

Research payments

$1,556,595

12 payments

Through program year 2025, Georgetown University Medical Ctr is reported as receiving $1,556,595 in research payments, across 12 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$173,707	1
2022	Research	$288,556	3
2021	Research	$299,963	3
2020	Research	$294,431	3
2019	Research	$499,938	2

Breakdown

Who paid Research payments · program years 2019–2025

Pfizer Inc. $1,556,595 12 payments

Studies the money was for Research payments · program years 2019–2025

2017 Aspire Oncology Hematology A Phase I Trial of Palbociclib and Bosutinib With Fulvestrant in Patients With Metastatic Hormone Receptor Positive and Her2 Negative Breast Cancer Refractory to An Aromatase Inhibitor and A Cdk4 6 Inhibitor $525,950 3 payments
A Pilot Trial of Induction Talazoparib Followed By Avelumab in Advanced Triple Negative Breast Cancer $478,725 3 payments
Wi231696 2017 Aspire Oncology Hematology A Phase I Trial of Palbociclib and Bosutinib With Fulvestrant in Patients With Metastatic Hormone Receptor Positive and Her2 Negative Breast Cancer Refractory to An Aromatase Inhibitor and A Cdk4 6 Inhibitor $342,582 3 payments
Wi236547 Talave A Pilot Trial of Induction Talazoparib Followed By Combination of Talazoparib and Avelumab in Advanced Breast Cancer $119,681 1 payment
Wi208808 2015 Aspire Breast Cancer Phase II Safety Study of Palbociclic in Combination With Letrozole in African American Women With Hormone Receptor Positive Her2 Negative Advanced Breast Cancer $89,656 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.